OpenRegistry
Companies House/London/Company profile

EPOCH BIODESIGN LTD

Active
11824812·incorporated 2019-02-13

EPOCH BIODESIGN LTD is an active UK private limited company, incorporated on 13 February 2019 at Companies House (number 11824812; OpenRegistry canonical ID GB-11824812-epoch-biodesign-ltd). Sophymarine's OpenRegistry classifies it under SIC 72110 (Research and experimental development on biotechnology), one of 4,219 active UK entities in that code and one of 1,093,852 active companies registered in London (postcode EC2A). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2019-02-13
Registered Address
10 FINSBURY SQUARE, LONDON, EC2A 1AJ, ENGLAND
SIC
72110 — Research and experimental development on biotechnology
Country of origin
United Kingdom

Accounts

Last filed accounts made up to 2025-03-31. Next accounts due 2026-12-31. Financial year-end: 31/03. Filing class: TOTAL EXEMPTION FULL.

Confirmation statement

Last confirmation statement made up to 2026-02-12. Next confirmation statement due 2027-02-26.

Mortgages and charges

1 charge recorded against the company at Companies House: 1 outstanding, 0 satisfied, 0 partially satisfied.

Persons with significant control

  • No individual or entity with significant control has been identified.

2 historical PSC records have ceased:

  • Dr Douglas Bruce Kell born 1953 resident in United Kingdom, British national. Notified 2019-02-13. Ceased 2023-10-10.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Mr Jacob Leon Nathan born 2000 resident in United Kingdom, British national. Notified 2019-02-13. Ceased 2024-11-13.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights

Previous names

EPOCH BIODESIGN LTD has previously traded as:

  • MELLIZYME BIOTECHNOLOGY LIMITED (until 2023-02-15)

Similar UK companies

Other companies registered under SIC 72110 (Research and experimental development on biotechnology):

Other companies registered in London: